ARTICLE | Company News
Deltagen to phenotype Schering-Plough genes
February 16, 2000 8:00 AM UTC
Deltagen (Menlo Park, Calif.) will use its DeltaSelect mammalian gene knockout and phenotyping technology to define gene function in vivo of small molecule drug targets from Schering-Plough Research I...